Forgot your password?
The agreement will focus on enhancing skin disease understanding
The phase 2 SCOPE study will evaluate the needle-free injection in patients with advanced unresectable cases of the disease
Researchers looked a naturally occurring peptide that regulates inflammation
Approximately 30% of psoriasis patients are affected by psoriatic arthritis
More than 26 million people in the US are affected by the inflammatory skin disease
The event brought together a broad range of experts and clinicians from across the world
KRP-M223 is being developed for CSU and other allergic and inflammatory diseases
Up to 20% of children and 10% of adults globally are affected by the skin disease
The immune-mediated skin disease impacts over 125 million people worldwide
The Stelara biosimilar has been authorised to treat plaque psoriasis and psoriatic arthritis